Wednesday, July 2, 2025

ImmersiveTouch Wins FDA Clearance for Breakthrough Augmented Reality Surgical System

Related stories

Blaize Raises $56M for Edge AI in Southeast Asia’s Infra

Blaize, a leader in edge AI computing, has secured...

Formant F3 Adds Gen AI, Agentic Reasoning to Robot Ops

Formant has announced the debut of F3, an AI-native...

CustomerInsights.AI Launches ciATHENA, an AI Platform for Pharma Analytics

CIAI announced the launch of ciATHENA, a next generation Agentic...

PhaseV Unveils ClinOps AI for Smarter Trial Site Picks

Powered by Causal AI and Real-Time Patient-Level Data and...

Accenture Acquires SYSTEMA to Boost Semiconductor Automation

Accenture has acquired SYSTEMA, a provider of software solutions...
spot_imgspot_img

ImmersiveTouch Inc., a leading digital surgery company, announced that its groundbreaking augmented reality (AR) technology platform, ImmersiveAR, has received 510(k) clearance for clinical use in the operating room by the U.S. Food and Drug Administration (FDA). The Chicago-based company will commence immediate commercialization of the platform in the United States.

ImmersiveAR is a natural extension of ImmersiveTouch’s AI-powered suite of virtual surgical planning products and services, which are already significantly improving CMF surgeries by reducing the traditional pre-operative planning workflow from seven days to just minutes. Surgeons can simulate surgical changes to bones and plan the final aesthetic result, tailoring the procedure to the patient’s unique anatomy, thereby minimizing errors and complications. ImmersiveTouch technology is an accretive solution for hospitals to generate additional reimbursement from payors and lower their healthcare costs.

Dr. David Hirsch, MD, DDS, Senior Vice President of Dental Medicine at Northwell Health, shared, “This virtual reality and augmented reality imaging provides remarkably detailed images of a patient’s anatomy, helping us foresee complications and reduce both planning and surgical time, resulting in a safer patient experience with fewer complications.”

Also Read: Octagos Health Secures Over $43 Million Investment to Advance AI-Driven Cardiac Device Monitoring

“ImmersiveAR brings a new frontier in intraoperative 3D visualization,” said Jay Banerjee, CEO of ImmersiveTouch. “The surgical field has long relied on traditional two-dimensional imaging technology to navigate complex patient anatomy. Our platform introduces advanced holographic visualization to transform how surgeons plan and perform procedures.”

ImmersiveAR allows surgeons to visualize and interact with 3D virtual surgical plans created by ImmersiveTouch or other virtual surgical planning providers, overlaid in an operating room environment for a fully integrated workflow from surgical planning to intraoperative 3D visualization. Surgeons can double-check their planned movements and reduce the need for intraoperative trial and error. The platform is designed for use in several surgical procedures.

This announcement follows significant company momentum, including strategic partnerships and a growing presence in leading hospitals. ImmersiveTouch has served over 4,000 patients, demonstrating its impact on the healthcare sector.

Source: Businesswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img